TELA Bio TELA 深 滬
等待開盤 09-09 09:30:00 美东时间
1.62
+0.030
+1.89%
華盛通- 最 高1.70
- 今 開1.60
- 成交量 5.14万股
- 最 低 1.59
- 昨 收 1.59
- 總市值 6407.91万
- 52周最高 3.26
- 市盈率 靜 --
- 換手率 0.13%
- 52周最低 0.8645
- 委 比 -87.79%
- 總股本 3955.50万
- 歷史最高 23.545
- 量 比 0.63
- 振 幅 6.92%
- 歷史最低 0.8645
- 每 手 1
- 風險率 0.66%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Wall Street Analysts Are Bullish on Top Healthcare Picks
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
08-13 19:10
TELA Bio shares are trading lower after the company reported worse-than-expected Q2 financial results.
TELA Bio shares are trading lower after the company reported worse-than-expecte...
08-12 22:18
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers FibroGen (NASDAQ:FGEN) shares rose 20.1% to $10.11 during Monday's aft...
08-12 05:06
TELA Bio Affirms FY2025 Sales Guidance of $85.000M-$88.000M vs $86.060M Est
TELA Bio (NASDAQ:TELA) affirms FY2025 sales outlook from $85.000 million-$88.000 million to $85.000 million-$88.000 million vs $86.060 million estimate.
08-12 04:49
TELA Bio Q2 EPS $(0.22) Misses $(0.18) Estimate, Sales $20.197M Miss $20.680M Estimate
TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.18) by 20.88 percent. This is a 56.86 percent increase over losses of $(0.51) per share from the
08-12 04:03
Earnings Scheduled For August 11, 2025
Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to rep...
08-11 16:32
TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference
TELA Bio, Inc. will participate in the Canaccord Genuity 45th Annual Growth Conference on August 13, 2025, at 10:00 am ET. The company's management will present, and interested parties can access the live or archived webcast via ir.telabio.com. TELA Bio focuses on providing innovative soft-tissue reconstruction solutions. For more information, contact Louisa Smith at ir@telabio.com.
07-23 20:03
TELA Bio to Announce Second Quarter 2025 Financial Results
TELA Bio, Inc. will release its Q2 2025 financial results on August 11, 2025, followed by a conference call and webcast at 4:30 p.m. ET. Interested investors must register in advance. TELA Bio focuses on innovative soft-tissue reconstruction solutions, emphasizing patient anatomy preservation and natural healing. The company is committed to providing effective and economical solutions for surgeons. This press release includes forward-looking stat...
07-21 20:03
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
TELA Bio Inc. granted an inducement compensation package including stock options for 75,000 shares and restricted stock units for 30,000 shares to Jim Hagen, Senior Vice President – Strategic Commercial Operations, with a grant date of June 2, 2025. The stock options have an exercise price of $1.42 per share and vest over four years, with the restricted stock units also vesting over four years, contingent on continued employment.
06-06 20:05
